Shares of Amarin Corp. rose dropped 5.5% toward a near three-month low in premarket trading Friday, after the biopharmaceutical company focused on therapies...
Shares of Amarin Corp.
rose dropped 5.5% toward a near three-month low in premarket trading Friday, after the biopharmaceutical company focused on therapies for cardiovascular health disclosed that Chief Executive Karim Mikhail has resigned, effective immediately, after about 19 months in the role. “Mr. Mikhail has asserted that he is entitled to severance payments as the result of his resignation, which the company disagrees with and intends to dispute,” Amarin said in a statement.
rose dropped 5.5% toward a near three-month low in premarket trading Friday, after the biopharmaceutical company focused on therapies for cardiovascular health disclosed that Chief Executive Karim Mikhail has resigned, effective immediately, after about 19 months in the role. “Mr. Mikhail has asserted that he is entitled to severance payments as the result of his resignation, which the company disagrees with and intends to dispute,” Amarin said in a statement.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Oscar Health's new CEO Mark Bertolini shares his plans for the insurerInsider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know.
Weiterlesen »
6 months and $8 billion dollars later, Dallas's Signify is CVS - CEO SpotlightKyle Armbrester, CEO, Signify Health joins KRLD's David Johnson on this episode of CEO Spotlight.
Weiterlesen »
DraftKings CEO Robins pockets more than $5 million from sale of stockDraftKings disclosed that CEO Jason Robins raised $5.3 million from the sale of stock.
Weiterlesen »
Groupon stock pops as company switches up its CEOGroupon Inc. is changing up its leadership, with Dusan Senkypl, the co-founder of Pale Fire Capital and a member of Groupon’s board, taking on the role of...
Weiterlesen »
Airbus drops offer for stake in Atos unit, shares tumbleAirbus has decided not to make an offer for a minority stake in Atos' soon-to-be spun-off division Evidian, sending shares in the French IT firm down more than 15%.
Weiterlesen »
Carl Icahn wants to bring back Illumina's ex-CEO 'immediately' as proxy fight intensifiesIcahn said Illumina should bring back former CEO Jay Flatley, saying current management is making the mistake of holding onto the $7.1 billion Grail deal.
Weiterlesen »